# NeoLight

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neolight

- Industry: Medical Devices & Equipment
- Headquarters: Scottsdale, US
- Website: www.theneolight.com
- Latest round: Seed (Jan 1, 2018)
- Investors on record: 1

## About

NeoLight, LLC is a US-based provider of innovative neonatal care solutions dedicated to addressing critical health challenges encountered by newborns, enhancing healthcare outcomes through advanced technologies.Founded in 2016 in Scottsdale, US, NeoLight, LLC specializes in neonatal care technologies. The company was co-founded by Deepak Krishnaraju and Vivek Kopparthi, with Arik Anderson currently serving as CEO. NeoLight has completed 10 funding deals, with the latest being a venture funding round on March 15, 2023, raising USD 5.65 mn. This funding represents the total amount raised by the company to date.NeoLight specializes in innovative neonatal care solutions that address critical health challenges for newborns. Their core product offerings include the nëo™ CFM with ClearWave™ aEEG, which enhances decision-making through advanced brain monitoring, and the ICON™ retinal imaging system that employs patented Direct Illumination™ technology for ocular screening. Additionally, the Skylife™ Neonatal Phototherapy System revolutionizes jaundice treatment by providing exceptional spectral power, which not only addresses jaundice but also encourages the development of non-nutritive sucking, facilitating oral feeding progression. These products are primarily utilized within neonatal intensive care units (NICUs) and are tailored for hospitals and healthcare providers focusing on improving outcomes for premature and at-risk infants. NeoLight targets both domestic and international markets, with a notable presence in North America, Europe, and select regions in Asia.Revenue generation for NeoLight is driven by direct sales and partnerships within the healthcare sector, specifically targeting neonatal care facilities. Transactions are structured primarily as business-to-business (B2B) sales, where hospitals and healthcare providers purchase their flagship products, including the Skylife™ system and the nëo™ CFM. The company may engage in long-term contracts for product supply or service agreements, ensuring that healthcare providers have ongoing access to cutting-edge neonatal solutions. Pricing structures for their offerings are typically reflective of specialized medical equipment standards, aligning with industry benchmarks for similar advanced healthcare technologies.Following the recent funding round completed in March 2023, which raised USD 5.65 mn, NeoLight plans to utilize the capital to support the development of new products and expand into additional geographic markets. Upcoming product launches are focused on enhancing neonatal care solutions, with specific details on release dates anticipated to be announced soon. NeoLight is targeting expansion into Europe and Asia by the end of 2024, aiming to increase its global footprint and improve healthcare outcomes for more newborns worldwide.

## Funding rounds

- Seed, Jan 1, 2018 — Revolution Ventures

## Investors

- Revolution Ventures (https://capitalatlas.ai/funds/revolution-ventures) — Seed